Loading...
Accord Healthcare Inc. — Cisplatin Import Profile: Suppliers, Formulations & Sources
Loading...
Pharmaceutical Importer · #15 buyer for Cisplatin · $148.5K import value · 3 shipments · CANADA · DGFT Verified
Accord Healthcare Inc. is the #15 importer of Cisplatin from India with $148.5K in import value and 3 verified shipments. Accord Healthcare Inc. holds a 1.2% market share in Cisplatin imports based in CANADA. Overall, Accord Healthcare Inc. imports 10 pharmaceutical products worth $5.0M across 6 therapeutic categories.
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| FRESENIUS KABI ONCOLOGY LIMITED | $2.8M | 60 | 8 |
| VENUS REMEDIES LIMITED | $1.7M | 121 | 22 |
| INTAS PHARMACEUTICALS LIMITED | $1.5M | 73 | 13 |
| MYLAN LABORATORIES LIMITED | $775.1K | 18 | 1 |
| GLAND PHARMA LIMITED | $530.1K | 11 | 1 |
| NAPROD LIFE SCIENCES PRIVATE LIMITED | $507.6K | 29 | 8 |
| UNITED BIOTECH PRIVATE LIMITED | $489.4K | 97 | 14 |
| INTAS PHARMACEUTICALS LTD | $268.6K | 15 | 9 |
| SP ACCURE LABS PRIVATE LIMITED | $233.8K | 27 | 9 |
| MEDORBIS TRADE LLP | $208.8K | 11 | 2 |
India's top Cisplatin suppliers include FRESENIUS KABI ONCOLOGY LIMITED, VENUS REMEDIES LIMITED, INTAS PHARMACEUTICALS LIMITED. These companies represent the primary source of Cisplatin exports from India, serving buyers like Accord Healthcare Inc. in CANADA and other global markets.
Buyers ranked immediately above and below #15 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 13 | FOSUN PHARMA USA INC | UNITED STATES | $200.0K | 4 | $50.0K |
| 9 | FRESENIUS KABI TAIWAN LTD | TAIWAN | $150.0K | 3 | $50.0K |
| 15 | ACCORD HEALTHCARE INC ★ | CANADA | $148.5K | 3 | $49.5K |
| 16 | ACCORD FARMACUTICA LTDA. | BRAZIL | $129.0K | 12 | $10.8K |
What Accord Healthcare Inc. and other importers must comply with to import Cisplatin from India
Health Canada (HC)
Abbreviated New Drug Submission (ANDS) referencing an approved Canadian Reference Product. Comparative bioavailability study required.
Typical timeline: 12–18 months
Health Canada GMP (GUI-0001); on-site Drug Establishment Licence (DEL) inspection
India exported $3.5M worth of Cisplatin through 1,701 shipments from 233 suppliers to 130 countries, serving 584 buyers globally. Accord Healthcare Inc. imports $148.5K of this total, accounting for 1.2% of India's Cisplatin exports with 3 shipments from CANADA.
Accord Healthcare Inc.'s average Cisplatin order value is $49.5K per consignment, based on 3 shipments totaling $148.5K. Accord Healthcare Inc. is based in CANADA and ranks #15 among all Cisplatin importers from India by value.
Top Indian Cisplatin suppliers include FRESENIUS KABI ONCOLOGY LIMITED ($2.8M), VENUS REMEDIES LIMITED ($1.7M), INTAS PHARMACEUTICALS LIMITED ($1.5M), MYLAN LABORATORIES LIMITED ($775.1K), GLAND PHARMA LIMITED ($530.1K). These companies represent the primary source of Cisplatin exports from India.
Accord Healthcare Inc. ranks #15 among 584 Cisplatin importers from India with a 1.2% market share. The top 3 importers are CSP MYLAN IRELAND LTD ($457.6K), FRESENIUS KABI TAIWAN LTD. ($400.0K), SCIEGEN PHARMACEUTICALS INC ($329.4K). Accord Healthcare Inc. processed 3 shipments from CANADA.
Accord Healthcare Inc. also imports these oncology products. Each links to the detailed product page.
Accord Healthcare Inc. imports 10 products worth $5.0M. Beyond Cisplatin, top products include Atorvastatin, Fluoxetine, Methotrexate, Calcium, Irinotecan. View the complete Accord Healthcare Inc. profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Cisplatin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify import regulations and drug registration requirements with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access order-level details, pricing data, supplier connections, and competitive analysis for Accord Healthcare Inc.'s Cisplatin imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Accord Healthcare Inc.
Full Company Profile →
10 products · $5.0M total trade · 6 categories
| 17 | ACCORD HEALTHCARE B V | NETHERLANDS | $127.1K | 6 | $21.2K |
Accord Healthcare Inc. ranks #15 among 584 Cisplatin importers from India. Average shipment value of $49.5K compared to the market average of $6.0K. The closest competitors by value are FOSUN PHARMA USA INC and FRESENIUS KABI TAIWAN LTD.
Drug Establishment Licence (DEL) for importer; Drug Identification Number (DIN) required
Bilingual (English/French) labeling required; Canadian format per Health Canada guidance
Note: Subject to C.01.014.6 annual review and Good Import Practices requirements.
Regulatory information is provided for general reference based on publicly available HC guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with HC or qualified regulatory affairs professionals for case-specific guidance.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 130+ countries, 584+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, supplier contacts, and formulation details for Accord Healthcare Inc..
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Cisplatin. For current order-level data, contact TransData Nexus.